diazooxonorleucine and Brain Neoplasms

diazooxonorleucine has been researched along with Brain Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Adams, R; Alt, J; Elgogary, A; Englert, J; Ferraris, D; Jančařík, A; Le, A; Majer, P; Monincová, L; Nedelcovych, M; Pate, K; Powell, J; Rais, R; Rojas, C; Slusher, BS; Tan, J; Tenora, L1
Hirose, Y; Ohba, S1
Arismendi-Morillo, G; Augur, ZM; Bronson, RT; Chinopoulos, C; Domin, MA; Greenwood, B; Hill, C; Kiebish, MA; Kondakci, G; Li, M; Mukherjee, P; Narain, NR; Seyfried, TN1
Huysentruyt, LC; Seyfried, TN; Shelton, LM1

Other Studies

4 other study(ies) available for diazooxonorleucine and Brain Neoplasms

ArticleYear
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
    Journal of medicinal chemistry, 2016, Sep-22, Volume: 59, Issue:18

    Topics: Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Diazooxonorleucine; Female; Glioblastoma; Glutamine; Haplorhini; Humans; Mice; Mice, Nude; Prodrugs

2016
L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
    Journal of neuro-oncology, 2020, Volume: 146, Issue:3

    Topics: Antineoplastic Agents; Asparaginase; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diazooxonorleucine; Glioblastoma; Humans

2020
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
    Communications biology, 2019, Volume: 2

    Topics: Animals; Body Weight; Brain; Brain Neoplasms; Caloric Restriction; Cell Line, Tumor; Cell Proliferation; Diazooxonorleucine; Diet, Ketogenic; Disease Models, Animal; Female; Fermentation; Glioblastoma; Glucose; Glutamine; Humans; Immunohistochemistry; Ketone Bodies; Ketones; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation

2019
Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    International journal of cancer, 2010, Nov-15, Volume: 127, Issue:10

    Topics: Animals; Antimetabolites, Antineoplastic; Blood Glucose; Body Weight; Brain Neoplasms; Caloric Restriction; Cell Growth Processes; Cell Line, Tumor; Cerebrum; Diazooxonorleucine; Drug Delivery Systems; Female; Glucose; Glutamine; Male; Mice; Neoplasm Metastasis

2010